Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...
Space looks peaceful from the outside. Astronauts float effortlessly, their movements fluid and graceful against the backdrop ...
By analyzing tissue from patients with Parkinson's disease, and animal and cellular models of the disease, a research team ...
White matter hyperintensity (WMH) burden predicts functional decline in real-world driving among older adults, according to a ...
New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...